Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference
Codexis (NASDAQ: CDXS), a provider of enzymatic solutions for therapeutics manufacturing, announced its participation in the Piper Sandler 36th Annual Healthcare Conference. The event will take place in New York from December 3-5, 2024. The company's management will engage in a fireside chat on December 3, 2024, at 11:00 am ET. Interested parties can access a live webcast through the company's investor relations website, with a replay available for 90 days after the event.
Codexis (NASDAQ: CDXS), fornitore di soluzioni enzimatiche per la produzione di terapeutiche, ha annunciato la sua partecipazione alla 36ª Conferenza Sanitaria Annuale di Piper Sandler. L'evento si svolgerà a New York dal 3 al 5 dicembre 2024. La direzione dell'azienda parteciperà a una conversazione informale il 3 dicembre 2024 alle 11:00 ora orientale. Le parti interessate possono accedere a una diretta web tramite il sito web delle relazioni con gli investitori dell'azienda, con una riproduzione disponibile per 90 giorni dopo l'evento.
Codexis (NASDAQ: CDXS), proveedor de soluciones enzimáticas para la fabricación de terapias, anunció su participación en la 36ª Conferencia Anual de Salud de Piper Sandler. El evento se llevará a cabo en Nueva York del 3 al 5 de diciembre de 2024. La gerencia de la empresa participará en una charla informal el 3 de diciembre de 2024 a las 11:00 a.m. hora del Este. Las partes interesadas pueden acceder a una transmisión web en vivo a través del sitio web de relaciones con inversores de la empresa, con una repetición disponible durante 90 días después del evento.
Codexis (NASDAQ: CDXS), 치료제 제조를 위한 효소 솔루션 제공업체, Piper Sandler 제36회 연례 의료 컨퍼런스에 참여한다고 발표했습니다. 이 행사는 2024년 12월 3일부터 5일까지 뉴욕에서 열립니다. 회사 경영진은 2024년 12월 3일 오전 11시(동부 표준시)에 대화 형식의 세션에 참석할 예정입니다. 관심 있는 분들은 회사의 투자자 관계 웹사이트를 통해 생중계에 액세스할 수 있으며, 이벤트 후 90일간 다시 볼 수 있습니다.
Codexis (NASDAQ: CDXS), fournisseur de solutions enzymatiques pour la fabrication de thérapies, a annoncé sa participation à la 36e Conférence Annuelle de Santé de Piper Sandler. L'événement aura lieu à New York du 3 au 5 décembre 2024. La direction de l'entreprise participera à une discussion informelle le 3 décembre 2024 à 11h00, heure de l'Est. Les parties intéressées peuvent accéder à un webinaire en direct via le site Web des relations avec les investisseurs de l'entreprise, avec une rediffusion disponible pendant 90 jours après l'événement.
Codexis (NASDAQ: CDXS), Anbieter enzymatischer Lösungen für die Herstellung von Therapeutika, gab seine Teilnahme an der 36. jährlichen Gesundheitskonferenz von Piper Sandler bekannt. Die Veranstaltung findet vom 3. bis 5. Dezember 2024 in New York statt. Das Management des Unternehmens wird am 3. Dezember 2024 um 11:00 Uhr MEZ an einem informellen Gespräch teilnehmen. Interessierte Personen können über die Website der Investorenbeziehungen des Unternehmens auf einen Live-Webcast zugreifen, der 90 Tage nach der Veranstaltung verfügbar ist.
- None.
- None.
REDWOOD CITY, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will attend the Piper Sandler 36th Annual Healthcare Conference, being held December 3-5, 2024, in New York, New York.
Management will participate in a fireside chat on Tuesday, December 3, 2024, at 11:00 am ET. A live webcast of the event will be available in the Investor Relations section of the Company’s website, https://ir.codexis.com. A replay will be archived for 90 days following the event.
About Codexis
Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis™ manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com.
For More Information
Investor Contact
Carrie McKim
(336) 608-9706
ir@codexis.com
Media Contact
Lauren Musto
(650) 421-8205
media@codexis.com
FAQ
When is Codexis (CDXS) presenting at the Piper Sandler Healthcare Conference 2024?
How can I watch Codexis (CDXS) presentation at the Piper Sandler Conference?
Where is the Piper Sandler Healthcare Conference 2024 being held?
